What is it?
GLP-RT3 is a next-generation GLP receptor targeting peptide for metabolic support and appetite regulation, supplied as a starting dose.
How does it work?
It targets the GLP receptor pathways involved in appetite, satiety and glucose handling, helping reduce food intake while supporting metabolic function.
What you need to know
Supplied deliberately as a starting dose. Titration and suitability are determined by your clinician following evaluation.
Peptide therapies require medical evaluation and may require a prescription. Certain therapies may involve compounded medications that are not FDA-approved. Individual results vary. See Medical & Regulatory Disclaimer.